COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FCC. EUROPA: UNICREDIT. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Europa pierde algo de altura A excepción del DAX que cerró en positivo se registraron caídas de cerca de medio punto en las principales bolsas de Europa ante las señales d...
NEWS SUMMARY: FCC. Slight drops in Europe Except for the DAX, which closed in positive numbers, the main European stock markets closed with losses of around -0.5% in view of the complacent markets and the political shutdown in France. In the STOXX 600, Construction and Utilities led the gains, while Autos (-4.5% on the day) and Consumer Goods suffered the biggest routs. On the macro side, in the euro zone, the ECB’s meeting minutes suggested the monetary policy is ready to respond to the change...
Seeing that the construction of the Belgian energy island is now progressing well, that the new CEO is acting stricter on cost control, that the demand for new bonds of Elia Transmission Belgium and 50Hertz has remained high at attractive yields, that the German regulator is expected to improve the regulatory rates framework for the next regulatory period, and that the investment fits perfectly in Europe’s ambitions to become less dependent on Russia, we today reiterate our Outperform recommenda...
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent obesity related comorbiditiesAkero Therapeutics’s FGF21 analogue efruxifermin is the only treatment to show significant fibrosis regression in phase 2 in patients with compensated cirrhosis (F4)Novo Nordisk to acquire Akero Therapeutics for 54 USD per share (4.7 billion USD) in cash at closing with a contingent value right (CVR) of 6 USD per s...
FERRARI CAPITAL MARKETS DAY TARGETING NEW HEIGHTS Ferrari upgrades the 2025 guidance, exceeding the 2026 business plan’s profitability targets one year in advanceStrong product mix over the plan sustains total revenues of Euro ~9.0 billion and an EBITDA of at least Euro 3.6 billion in 2030Continuous innovation in products for the longer term, with cumulated capital expenditures of Euro ~4.7 billion over the plan and a significant portion dedicated to the next generation of sports carsRobust industrial free cash flow generation of Euro ~8.0 billion over the plan and improved cash conversion...
FERRARI CAPITAL MARKETS DAY 2030 STRATEGIC PLAN THE UNIQUENESS OF OUR OFFERING, OUR CLIENTS AND OUR EXPERIENCES An average of four new car launches per year planned between 2026 and 2030The Ferrari elettrica will be an addition to the range product offeringIn 2030, the product line-up will be 40% ICE, 40% hybrid and 20% electric90,000 active clients – a 20% increase compared to 2022Opening of new Tailor Made centers in Tokyo and Los Angeles, to get closer to our clients CONTINUOUS INNOVATION AND PRODUCT DIVERSIFICATION Continuous investments in sports car development, in line with the pr...
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Maranello (Italy), October 6, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the “Eighth Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) as fol...
EME Equity Market – September 2025 Romanian BET led in September, while Türkiye and Hungary lagged. The MSCI EM Europe Index added 0.7% mom in EUR terms and 1.1% in USD terms. The Romanian BET was the top performer, adding 3.6% in EUR terms; followed by the Czech PX (+3.2% mom) and the Polish WIG20 (+1.1% mom) (all in EUR terms); while there was a muted performance from the Greek ASE (+0.6% mom in EUR terms). The Turkish ISE30 and the Hungarian BUX were the worst performing indices in September(...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.